Stockpolly
Search
BSEM · NASDAQ · Biotechnology

BioStem Technologies (BSEM)

Manufacturer of placental-tissue allografts for wound care and surgical applications.

$3.58
Pre-market+0.02 (+0.56%)
At close$3.56(+1.71%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Insiders10 holders · as of Aug 28, 202616.77%2.99M shares
Otherremainder83.23%14.86M shares

17.85M company shares as of Sep 3, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Vurst Andrew Smith-VanInsiderdirector, 10 percent owner, officer: Chief Operating Officer
8.53%1.52MForm 4filed Aug 14, 2026 ↗
Jason MatuszewskiInsiderdirector, 10 percent owner, officer: Chief Executive Officer
7.16%1.28MForm 4filed Aug 14, 2026 ↗
Michael A. FortunatoInsiderofficer: Chief Accounting Officer
0.36%64,430Form 4filed Aug 20, 2026 ↗
Brandon PoeInsiderofficer: Chief Financial Officer
0.32%56,368Form 4filed Aug 20, 2026 ↗
Kenneth Howard Jr WarringtonInsiderdirector
0.18%32,234Form 4filed Aug 28, 2026 ↗
Jodi UngrodtInsiderdirector
0.06%11,295Form 4filed Aug 28, 2026 ↗
Mark A. GlickmanInsiderdirector
0.04%7,671Form 4filed Aug 28, 2026 ↗
Hannaway Rayna LesserInsiderdirector
0.04%7,671Form 4filed Aug 28, 2026 ↗
Steven D. SonenreichInsiderdirector
0.04%7,671Form 4filed Aug 28, 2026 ↗
Barry HassettInsiderofficer: Chief Commercial Officer
0.03%4,503Form 4filed Aug 14, 2026 ↗

Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.